Chronic PET‐Microplastic Exposure: Disruption of Gut–Liver Homeostasis and Risk of Hepatic Steatosis
Advanced Science · 2026-01 · 13 (1)
DOI: 10.1002/advs.202512030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.10.2025. Verfasst von Surye Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biosciences, Kyungpook National University, Daegu, 41566, Republic of Korea. Hauptthemen laut MEDLINE: Homeostasis, Liver, Fatty Liver, Microplastics. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education, Korea Basic Science Institute (National research Facilities and Equipment center).
Abstract (Originalsprache)
Microplastics (MPs) are pervasive pollutants found in environments and food, with humans experiencing continuous exposure. Polyethylene terephthalate (PET) is a major plastic contaminant detected in food and beverages. However, the chronic effects of environmentally relevant, physically abraded PET‐MPs on health, on the liver, remain elusive. This study investigates the hepatotoxicity of the PET‐MPs following long‐term exposure, with a focus on the gut–liver axis interactions and transcriptomic responses. Male mice are exposed to PET‐MPs (5 mg week −1 ) from 5 to 34 weeks of age. Environmentally mimetic PET particles are prepared by grinding plastic bottles. Prolonged exposure to MPs for 29 weeks led to increased adiposity and obesity. The mice exposed to PET‐MPs developed hepatomegaly, steatosis, and early‐stage fibrosis. Transcriptome data revealed the downregulation of genes involved in mitochondrial energy metabolism and the upregulation of lipid droplet and fibrotic pathway genes. Gut microbiota is also significantly changed, with a decrease in Bacteroides and Lachnospiraceae , which maintain gut homeostasis. Disruption of bile acid metabolism and fecal color change further indicated impairment of the gut–liver axis. These findings provide new toxicological insights and emphasize the requirement to reassess the public health risks posed by long‐term MPs ingestion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biosciences, Kyungpook National University, Daegu, 41566, Republic of Korea.
- NGS Core Facility, Kyungpook National University, Daegu, 41566, Republic of Korea.
- College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241, Republic of Korea.
- Department of Anatomy & Cell Biology, School of Medicine, Kangwon National University, Chuncheon, 24341, Republic of Korea.
- Brain Health Research Laboratory, Institute of Medical Science, Kangwon National University College of Medicine, Chuncheon, 24341, Republic of Korea.
ORCID-Profile: Surye Park, Min-Ji Kim, Jae-Ho Shin, Eunsoo Kim, Myeongjoo Son, Seungjun Lee
Förderung
- National Research Foundation of Korea
- Ministry of Education
- Korea Basic Science Institute (National research Facilities and Equipment center)
- Ministry of Education (MOE) and Daegu Metropolitan City, Republic of Korea
- Kementerian Pendidikan
Zitieren
APA
Park, S., Kim, M. J., Shin, J. H., Kim, E., Son, M., & Lee, S. (2026). Chronic PET‐Microplastic Exposure: Disruption of Gut–Liver Homeostasis and Risk of Hepatic Steatosis. Advanced Science, 13(1). https://doi.org/10.1002/advs.202512030
Vancouver
Park S, Kim MJ, Shin JH, Kim E, Son M, Lee S. Chronic PET‐Microplastic Exposure: Disruption of Gut–Liver Homeostasis and Risk of Hepatic Steatosis. Advanced Science. 2026;13(1). doi:10.1002/advs.202512030
BibTeX
@article{Park2026,
author = {Park, Surye and Kim, Min-Ji and Shin, Jae-Ho and Kim, Eunsoo and Son, Myeongjoo and Lee, Seungjun},
title = {Chronic PET‐Microplastic Exposure: Disruption of Gut–Liver Homeostasis and Risk of Hepatic Steatosis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {1},
doi = {10.1002/advs.202512030}
}
EUVIMED